US2010034805A1PendingUtilityA1

Kallikrein-inhibitor therapies

Individually held — no corporate assignee on recordPriority: Jun 7, 2002Filed: Oct 31, 2007Published: Feb 11, 2010

Est. expiryJun 7, 2022(expired)· nominal 20-yr term from priority

Inventors:Robert Charles Ladner Arthur C. Ley Shirish Hirani Anthony Williams

A61P 9/10A61P 43/00A61P 7/00A61P 25/00A61K 38/57

PatentIndex Score

Cited by

References

Claims

Abstract

Methods are described for preventing or reducing ischemia, e.g., cerebral ischemia, and/or reperfusion injury, e.g., reperfusion injury associated with cerebral ischemia, in a patient.

Claims

exact text as granted — not AI-modified

1 .- 13 . (canceled) 
     
     
         14 . A method for preventing or reducing perioperative blood loss in a patient, the method comprising:
 administering to the patient a composition comprising an anti-plasma kallikrein antibody, in an amount effective to for preventing or reducing perioperative blood loss in a patient.

Join the waitlist — get patent alerts

Track US2010034805A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.